Today: 7 June 2026
Amazon’s Stock Skyrockets: Q3 Beat, Cloud and AI Boom Fuel Rally
7 November 2025
3 mins read

AMZN Pre‑Market Today (Nov. 7, 2025): Price, Key Headlines, and What to Watch Before the Bell

Summary (read in 30 seconds): Amazon.com, Inc. (NASDAQ: AMZN) is indicating lower before the U.S. market open after a headline‑packed week that included a seven‑year, $38B AWS deal with OpenAI, a Q3 beat with the fastest AWS growth since 2022, and an AWS service disruption that has since recovered. This morning brings fresh company updates (including new AWS initiatives and Prime Video programming drops) and a handful of AWS service lifecycle changes that become effective today.


Pre‑Market Snapshot (as of 10:25 UTC, Nov. 7, 2025)

  • AMZN price indication:$243.04, roughly ‑2.86% versus Thursday’s close. For context, Thursday’s previous close was $250.20.
  • 52‑week range: $161.38 – $258.60 (record set Nov. 3, 2025). This morning’s indication sits about 6% below that high.

Note: Pre‑market prices are thin and can change quickly; always check a live quote near the open.


What’s New This Morning (Nov. 7)

  • AWS x Jane Goodall Institute: Amazon highlights a new collaboration to digitize 60 years of primate research with AI—another illustration of AWS’s applied‑AI narrative heading into year‑end.
  • Prime Video programming lands today: Season 2 of Maxton Hall – The World Between Us debuts, adding incremental engagement fodder ahead of the peak shopping season.
  • AWS lifecycle changes take effect today: Several legacy or specialized modernization tools stop onboarding new customers as AWS steers enterprises toward newer offerings (e.g., AWS Transform). Watch for migration notes around App2Container, Microservice Extractor for .NET, and the Managed Runtime Environment track of AWS Mainframe Modernization.
  • International commerce positioning: Amazon reiterated ambitions for Vietnam to become a high‑quality e‑commerce export hub in Southeast Asia—useful color for third‑party (3P) marketplace growth and cross‑border logistics focus.

The Big Drivers From This Week (Still Moving the Stock)

  1. OpenAI picks AWS in a seven‑year, $38B deal. OpenAI will tap “hundreds of thousands” of Nvidia GPUs at AWS, diversifying its cloud stack and validating AWS’s AI capacity. Shares rallied on the announcement earlier this week. Reuters+2apnews.com+2
  2. Q3 2025 recap: AWS accelerates; holidays guide in focus. Amazon posted ~20% YoY AWS revenue growth—its fastest since 2022—while projecting Q4 net sales of $206B–$213B, putting a spotlight on holiday execution and incremental AI‑driven cloud demand.
  3. AWS outage and recovery (Nov. 5). After a mid‑week service disruption flagged by Downdetector, Amazon reported services were functioning normally, easing infrastructure‑resilience concerns after October’s larger event.
  4. Workforce alignment and cost structure. Late October updates signaled ~14,000 corporate job reductions tied in part to the AI pivot; investors continue to assess margin effects as capex tilts to data centers and silicon.
  5. Legal & ecosystem watch:
    • FTC Prime settlement—refunds program continues (total $2.5B, including $1.5B for customer refunds) with compliance obligations on enrollment/cancellation flows.
    • Platform integrity & AI agents: Amazon signaled legal pressure on third‑party AI tools accessing its marketplace without authorization—part of a broader policy stance as agentic shopping tools proliferate.

How Today’s Tape Could Set Up

  • Positioning vs. recent highs: After touching an all‑time/52‑week high near $258.60 earlier this week, AMZN is indicating lower pre‑market. A durable re‑test will likely require confirmation that AWS momentum (plus the OpenAI deal) offsets higher AI capex into 2026.
  • Holiday lens: Early seasonal promotions are underway across Amazon’s retail surfaces; investors usually parse traffic, conversion, and advertising take‑rate to gauge Q4 leverage. (Management guided Q4 net sales to $206B–$213B last week.)
  • Cloud and reliability narrative: The OpenAI partnership bolsters the “capacity and competitiveness” storyline after October’s outage chatter; any additional service‑health updates remain a near‑term swing factor. Reuters+1

Key Numbers & Context

  • Pre‑market (10:25 UTC):$243.04 (approx. ‑2.86% vs. prior close).
  • Prior close (Nov. 6):$250.20. 52‑week high:$258.60 set Nov. 3, 2025.
  • Q4 revenue guide:$206B–$213B; AWS Q3 growth:~20% YoY (fastest since 2022).
  • OpenAI x AWS:$38B, seven‑year cloud agreement; usage already beginning with capacity ramping through 2026–27.

What to Watch After the Opening Bell

  • AWS momentum: Look for sell‑side and customer updates quantifying the OpenAI demand tailwind and any incremental AI wins (Anthropic, enterprise GenAI pilots, data‑center expansion cadence).
  • Holiday KPIs: Third‑party checks on deal engagement, delivery speed, and ad load into Black Friday/Cyber Week; ad growth was a profit lever last quarter.
  • Policy & platform integrity: Any developments in the FTC settlement implementation and enforcement around unapproved AI “shopping agents” scraping or transacting on Amazon’s marketplace. ftc.gov+1
  • Service reliability: Follow the AWS Health Dashboard/company communications for any residual impacts post‑Wednesday’s disruption.

Bottom Line

AMZN enters Friday’s session near $243 pre‑market, consolidating a powerful week‑long AI‑cloud re‑rating driven by the OpenAI deal and a solid Q3 print. Short‑term, the battle is between AI capex optics and AWS demand confidence into 2026; near‑term trading likely keys off AWS headlines, holiday updates, and any reliability notes.


Disclosure: This article is for informational purposes only and is not investment advice. Always do your own research and consider your financial objectives and risk tolerance before trading.

Stock Market Today

  • Bioventix shares down 43% with 9% dividend yield: a buying opportunity?
    June 7, 2026, 3:07 AM EDT. Bioventix (LSE:BVXP), a UK biotech firm specialising in monoclonal antibodies for diagnostics, has seen its share price fall 43% over 12 months amid weak demand and competition, particularly in China. Despite this, it offers a 9% dividend yield, supported by a strong balance sheet and high-margin royalty model. Recent results show a 5% drop in profit before tax to £10.1m, with sales to Chinese diagnostic companies falling. However, royalties from neurological antibodies have grown fivefold, suggesting emerging long-term prospects. Investors face risks from market concentration but management's dividend maintenance reflects confidence in future growth and potential for a share price rebound.

Latest articles

UiPath Stock Set for Inflation Test After Swings in AI-Driven Trading

UiPath Stock Set for Inflation Test After Swings in AI-Driven Trading

7 June 2026
UiPath shares fell 3.68% to $11.24 Friday, wiping out Monday’s 11.77% rally despite reporting 17% revenue growth and its first-ever first-quarter GAAP profit, as a broader tech selloff and persistent analyst “Hold” ratings outweighed strong guidance and new customer wins.
Caterpillar flat at end of strong week, inflation on radar

Caterpillar flat at end of strong week, inflation on radar

7 June 2026
Caterpillar tumbled 3.85% Friday to $904.28 after hitting a 52-week high, as a strong jobs report sent Treasury yields soaring and triggered a broad market selloff; despite the drop, Caterpillar remains up 3.2% for the week, with investors now weighing its record backlog and first-quarter growth against rising rate risks and a more cautious market.
Nuclear decision gives Constellation boost, but CEG stock slides

Nuclear decision gives Constellation boost, but CEG stock slides

7 June 2026
Constellation Energy shares closed at $254.83, down 3.7% and 11% below the $287.75 price in last week’s prospectus, after a shareholder offering and despite a regulatory win for its Three Mile Island restart plan; investors now face a weekend to digest new stock supply, rate worries, and nuclear project risks before Monday’s open.
Portnoy’s Bitcoin, XRP Losses Mount In $390B Crypto Drop

Portnoy’s Bitcoin, XRP Losses Mount In $390B Crypto Drop

7 June 2026
Strategy’s surprise sale of 32 Bitcoin for $2.5 million to fund preferred stock distributions rattled investors, raising fears it may sell more to meet obligations, as Bitcoin and Ether posted their worst weekly losses since 2022 and crypto-linked stocks like Coinbase and Robinhood plunged up to 11% amid a $390 billion market wipeout.
Bitcoin Hits $60,000 As Crypto Selloff Deepens

Bitcoin Drops as ETF Outflows Mount, $60,000 Support Weakens

7 June 2026
Bitcoin plunged below $60,000 for the first time since October 2024, triggering $4.4 billion in spot ETF outflows and a rare bitcoin sale by Strategy, while crypto-linked stocks tumbled and analysts warned that further drops below $59,750 could spark more selling pressure or a deeper slide.
Upstart Holdings’ AI Lending Revolution: Surging Growth, Stock Turmoil, and What’s Next for UPST
Previous Story

Upstart Holdings’ AI Lending Revolution: Surging Growth, Stock Turmoil, and What’s Next for UPST

FTSE 100’s Record Run: Inside London’s Blue-Chip Rally and What’s Next
Next Story

FTSE 100 Jumps on US Shutdown Hopes as Diageo Soars; BoE Stablecoin Plan and Gold Rally Lift London Stocks — UK Market Wrap (10 November 2025)

Go toTop